4 Recruiting Idiopathic Pulmonary Fibrosis Phase 3 Clinical Trials

Active phase 3 studies for idiopathic pulmonary fibrosis enrolling across the USA. Verify eligibility and contact site coordinators.

All Idiopathic Pulmonary Fibrosis studies

Phase 3 Studies for Idiopathic Pulmonary Fibrosis

🔵 Active, Not Recruiting Phase3

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

📍 Local Institution - 0189 — Birmingham, Alabama

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase3

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase3

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

📍 Pulmonary Specialists of The Palm Beaches — Loxahatchee Groves, Florida

View Study & Checklist ➔

🟢 Recruiting Phase3

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

📍 University of Alabama at Birmingham — Birmingham, Alabama

View Study & Checklist ➔